RESTASIS ophthalmic emulsion based on Cyclosporine, which is an immunosuppressive agent. Cyclosporine ophthalmic may reduce inflammation in the eye(s).
RESTASIS ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.
Restasis and Cyclosporine ophthalmic may also be used for purposes other than those listed in this medication guide.